DK0477903T3 - Substituerede 4-amino-3-pyridinoler, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler - Google Patents

Substituerede 4-amino-3-pyridinoler, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Info

Publication number
DK0477903T3
DK0477903T3 DK91116336.8T DK91116336T DK0477903T3 DK 0477903 T3 DK0477903 T3 DK 0477903T3 DK 91116336 T DK91116336 T DK 91116336T DK 0477903 T3 DK0477903 T3 DK 0477903T3
Authority
DK
Denmark
Prior art keywords
loweralkyl
chem
hydrogen
preparation
pyridinols
Prior art date
Application number
DK91116336.8T
Other languages
Danish (da)
English (en)
Inventor
Kevin James Kapples
Gregory Michael Shutske
John Dick Tomer
Nicholas Joseph Hrib
John Gerard Jurcak
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DK0477903T3 publication Critical patent/DK0477903T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Surface Treatment Of Glass (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK91116336.8T 1990-09-27 1991-09-25 Substituerede 4-amino-3-pyridinoler, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler DK0477903T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58911390A 1990-09-27 1990-09-27

Publications (1)

Publication Number Publication Date
DK0477903T3 true DK0477903T3 (da) 1996-07-29

Family

ID=24356648

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91116336.8T DK0477903T3 (da) 1990-09-27 1991-09-25 Substituerede 4-amino-3-pyridinoler, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Country Status (22)

Country Link
US (3) US5821239A (el)
EP (1) EP0477903B1 (el)
JP (1) JP3090511B2 (el)
KR (1) KR100215357B1 (el)
AT (1) ATE136297T1 (el)
AU (1) AU637720B2 (el)
CA (1) CA2052433C (el)
CZ (1) CZ282002B6 (el)
DE (1) DE69118470T2 (el)
DK (1) DK0477903T3 (el)
ES (1) ES2085940T3 (el)
FI (1) FI914504A (el)
GR (1) GR3019742T3 (el)
HU (1) HUT60247A (el)
IE (1) IE73874B1 (el)
IL (1) IL99581A (el)
NO (1) NO913778L (el)
NZ (1) NZ239935A (el)
PT (1) PT99073B (el)
TW (1) TW200462B (el)
YU (1) YU158591A (el)
ZA (1) ZA917692B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
FR2813891B1 (fr) * 2000-09-14 2005-01-14 Immunotech Sa Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
DE10102791B4 (de) * 2001-01-22 2004-04-15 Ifm Electronic Gmbh Elektrischer Meßumformer
HUP0501011A3 (en) * 2001-12-14 2009-04-28 Novo Nordisk As Carbamates as hormone-sensitive lipase inhibitors, process for producing them, pharmaceutical compositions containing them and their use
KR100443983B1 (ko) 2002-01-15 2004-08-09 삼성전자주식회사 냉장고
US8007826B2 (en) * 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
PL1849773T3 (pl) * 2005-02-17 2014-03-31 Astellas Pharma Inc Pochodne piperazyny do leczenia nietrzymania moczu i bólu
AU2009291781A1 (en) * 2008-09-10 2010-03-18 Acorda Therapeutics, Inc. Methods of using sustained release aminopyridine compositions
BR112012019923A2 (pt) 2010-02-09 2016-08-09 Univ Johns Hopkins métodos e composições para melhorar a função cognitiva
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
GEP201706739B (en) 2012-12-13 2017-09-25 H Lundbeck As Compositions comprising vortioxetine and donepezil
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CN107810002B (zh) 2015-05-22 2021-01-05 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179563A (en) * 1978-05-19 1979-12-18 Warner-Lambert Company 3-Aryloxy-substituted-aminopyridines and methods for their production
US4734275A (en) * 1983-08-19 1988-03-29 Research Corporation Anti-curare agents
DE3514073A1 (de) * 1985-04-18 1986-10-23 Hoechst Ag, 6230 Frankfurt Mehrfach substituierte pyridin-1-oxide, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
US4735958A (en) * 1986-12-22 1988-04-05 Warner-Lambert Company Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-substituted-1H-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one inhibitors of cholesterol biosynthesis
US4831044A (en) * 1987-10-29 1989-05-16 Ici Americas Inc. Fungicidal pyridyl cyclopropane carboxamidines
US4994473A (en) * 1987-11-17 1991-02-19 Ici Americas Inc. Pyridyl containing insecticides
EP0361489A3 (en) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
KR0156241B1 (ko) * 1988-11-16 1998-11-16 도날드 알.토센 하이드록시-1,2,3,4-테트라하이드로아미노아크리딘, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US4931457B1 (en) * 1989-06-28 1993-11-16 Hoechst-Roussel Pharmaceuticals Incorporated Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders

Also Published As

Publication number Publication date
IL99581A0 (en) 1992-08-18
GR3019742T3 (en) 1996-07-31
NO913778L (no) 1992-03-30
AU8475691A (en) 1992-04-02
IE73874B1 (en) 1997-07-02
PT99073B (pt) 1999-02-26
DE69118470D1 (de) 1996-05-09
EP0477903A2 (en) 1992-04-01
FI914504A (fi) 1992-03-28
FI914504A0 (fi) 1991-09-25
EP0477903B1 (en) 1996-04-03
US5821239A (en) 1998-10-13
IE913389A1 (en) 1992-04-08
AU637720B2 (en) 1993-06-03
CA2052433A1 (en) 1992-03-28
CZ282002B6 (cs) 1997-04-16
ATE136297T1 (de) 1996-04-15
TW200462B (el) 1993-02-21
KR920006318A (ko) 1992-04-27
ZA917692B (en) 1992-05-27
IL99581A (en) 1995-07-31
DE69118470T2 (de) 1996-09-19
PT99073A (pt) 1992-08-31
US5866565A (en) 1999-02-02
JP3090511B2 (ja) 2000-09-25
ES2085940T3 (es) 1996-06-16
HU913075D0 (en) 1992-01-28
YU158591A (sh) 1994-12-28
HUT60247A (en) 1992-08-28
CA2052433C (en) 2003-04-15
NO913778D0 (no) 1991-09-26
CS293691A3 (en) 1992-04-15
EP0477903A3 (en) 1992-08-05
US5869480A (en) 1999-02-09
NZ239935A (en) 1995-07-26
JPH04261157A (ja) 1992-09-17
KR100215357B1 (ko) 1999-08-16

Similar Documents

Publication Publication Date Title
DK0477903T3 (da) Substituerede 4-amino-3-pyridinoler, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK0484573T3 (da) Physostigmin-beslægtede 4- og 6-carbamater, en fremgangsmåde og mellemprodukter til deres fremstilling og deres anvendelse som lægemidler
ATE162521T1 (de) 3-aminopiperidine derivate und verwandete stickstoff enthaltende heterocyclische verbindungen
NO178889C (no) [(Arylalkylpiperidin-4-yl)metylÅ-2a,3,4,5-tetrahydro-1(2H)-acenaftylen-1-oner og beslektede forbindelser
DK0468401T3 (da) 1-(Substitueret pyridylamino)-1H--indol-5-yl-substituerede carbamater, fremgangsmåde til deres fremstilling samt deres anve
NO923686D0 (no) Substituerte pyridinylamino-1h-indoler, 1h-indazoler, 2h-indazoler, benzo(b)-thiofener og 1,2-benzisotiazoler, en fremgangsmaate for deres fremstilling og deres anvendelse som legemidler
FI875145A (fi) Kondenserade heterocykliska tetrahydroaminokinoliner och beslaektade foereningar, en metod foer deras framstaellning och deras anvaendning som mediciner.
DK0405342T3 (da) (1,2,3,4-Tetrahydro-9-acridinimino)cyclohexancarboxylsyre og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ES2102774T3 (es) Indolsulfonamidas como agentes antitumorales.